​

Pasithea Therapeutics Ownership | Who Owns Pasithea Therapeutics?

OverviewFinancialsChart

Pasithea Therapeutics Ownership Summary

Pasithea Therapeutics is owned by 0.45% institutional investors, 1.52% insiders, and 98.03% retail investors. Magnolia private wealth is the largest institutional shareholder, holding 0.45% of KTTA shares. AdvisorShares Psychedelics ETF is the top mutual fund, with 1.46% of its assets in Pasithea Therapeutics shares.

KTTA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPasithea Therapeutics0.45%1.52%98.03%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Magnolia private wealth33.33K0.45%$43.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Magnolia private wealth33.33K0.03%$43.00K

Top Buyers

HolderShares% AssetsChange
Magnolia private wealth33.33K0.03%33.33K

Top Sellers

HolderShares% AssetsChange
Magnolia private wealth33.33K0.03%33.33K

New Positions

HolderShares% AssetsChangeValue
Magnolia private wealth33.33K0.03%33.33K$43.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20251-33,333---1---
Dec 31, 20238-33.33%248,808-2.59%-103.48%3-57.14%2-33.33%
Sep 30, 202312-255,417-32.44%-46.49%740.00%3-
Jun 30, 202312-378,085-1.83%166.46%525.00%3-
Mar 31, 2023129.09%385,124-39.00%123.62%4-50.00%350.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
AdvisorShares Psychedelics ETF337.51K1.46%-
Vanguard Institutional Extnd Mkt Idx Tr53.81K0.23%-
Fidelity Extended Market Index41.90K0.18%27.19K
NT Ext Equity Mkt Idx Fd - L19.37K0.08%17.70K
Fidelity Series Total Market Index7.97K0.03%-
NT Ext Eq Mkt Indx Fd DC Lending Tier 57.59K0.03%7.12K
NT Ext Eq Mkt Indx Fd DC Lend T4399.000.03%399.00
NT Ext Eq Mkt Indx Fd DC Lend T3399.000.03%399.00
Spartan Total Market Index Pool G4.61K0.02%1.83K
Spartan Total Market Index Pool E229.000.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 28, 2025STEINMAN LAWRENCE-Buy$100.00K
Nov 28, 2025Marques Tiago Chief Executive OfficerBuy$25.00K
Nov 28, 2025Dumesnil Simon-Buy$25.00K
May 12, 2025Marques Tiago Chief Executive OfficerSell$792.00
Jun 02, 2023STEINMAN LAWRENCE-Buy$12.93K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1--
2023 Q21-
2022 Q41-
2022 Q313-

KTTA Ownership FAQ

Who Owns Pasithea Therapeutics?

Pasithea Therapeutics shareholders are primarily institutional investors at 0.45%, followed by 1.52% insiders and 98.03% retail investors. The average institutional ownership in Pasithea Therapeutics's industry, Biotech Stocks , is 381.47%, which Pasithea Therapeutics falls below.

Does Blackrock own Pasithea Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Pasithea Therapeutics.

Who is Pasithea Therapeutics’s biggest shareholder by percentage of total assets invested?

Magnolia private wealth is Pasithea Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 33.33K Pasithea Therapeutics shares, valued at 43K$.

Who is the top mutual fund holder of Pasithea Therapeutics shares?

AdvisorShares Psychedelics ETF is the top mutual fund holder of Pasithea Therapeutics shares, with 1.46% of its total shares outstanding invested in 337.51K Pasithea Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools